InvestorsHub Logo

123414

08/14/19 10:17 AM

#205287 RE: 123414 #205136

$TLTFF-Patent to Destroy Cancer Cells with X-Ray Activated

Theralase® Granted United States Patent to Destroy Cancer Cells with X-Ray Activated Photo Dynamic Compounds

Toronto, Ontario – March 4, 2019
Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations intended to safely and effectively destroy various cancers, announced today that it has been granted allowance for a United States patent to issue later this year for destroying cancer cells with X-ray activated PDCs.

The new patent to issue later this year is entitled, “Photodynamic Compounds and Methods for Activating Them Using Ionizing Radiation and/or Other Electromagnetic Radiation for Therapy and/or Diagnostics”

https://theralase.com/pressrelease/theralase-granted-united-states-patent-to-destroy-cancer-cells-with-x-ray-activated-photo-dynamic-compounds/

123414

08/28/19 10:04 AM

#206163 RE: 123414 #205136

TLTFF- Way oversold on emotions.

PPS reflects nervous impatient emotional shareholders.

The company's fundamentals and science are solid.

Money in the bank to fund the PH2 study.

The pre meeting with the FDA for IND went great.

Patients enrolled and being screened for treatment.

Patient 18 months cancer free with one treatment.

204 million shares out.